Lee Frank D.

Director at BHC; President and CEO at Forma Therapeutics Holdings, Inc.,

Sold, on record
$431k
Dollars the filings state
Form 4 sales
3
Latest May 19, 2026
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

1
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale Forma Therapeutics Holdings, Inc.,Plan not stated
    Feb 23, 2022 2022

    Sold 17,981 shares at $9.78 ($176k)

    Lee Frank D., President and CEO

    Sold 18.4% of holdings ($956k position)79,769 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale BHCNo plan
    Aug 21, 2025 +1275 days

    Sold 15,912 shares at $7.66 ($122k)

    Lee Frank D., Director

    No 10b5-1 planSold 17.7% of holdings ($687k position)73,795 shares leftFirst sale on recordFiling

  3. 3 Form 4 sale BHCRoutine
    May 19, 2026 +271 days

    Sold 24,456 shares at $5.43 ($133k)

    Lee Frank D., Director

    10b5-1 planSold 33.1% of holdings ($401k position)49,339 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Lee Frank D.
Source
May 19, 2026May 20, 2026BHCDirectorForm 4 sale24,456$133k33.1%RoutineSEC
Aug 21, 2025Aug 22, 2025BHCDirectorForm 4 sale15,912$122k17.7%No planSEC
Feb 23, 2022Feb 25, 2022Forma Therapeutics Holdings, Inc.,President and CEOForm 4 sale17,981$176k18.4%Plan not statedSEC